Light-Activated gel shows promise for psoriasis in early trial
Disease control
Completed
This study tested a gel called SGX302, which is activated by visible light, on 15 people with mild-to-moderate plaque psoriasis. The goal was to see if it could clear or nearly clear skin lesions over 18 weeks. The treatment is applied to the skin and then exposed to light, aimin…
Phase: PHASE2 • Sponsor: Soligenix • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC